Pharmafile Logo
Pharmafocus logo
Advanced Search

Spark Therapeutics

Showing 9 posts of 9 posts found.

Roche set to acquire Spark Therapeutics in $4.8 billion deal

February 25, 2019
Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma

Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards …

News
spark_v2

Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%

August 8, 2018
Research and Development Spark Therapeutics, haemophilia, pharma

Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …

News
spark_v2

Spark hands over Luxturna rights outside US to Novartis for $170m

January 25, 2018
Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma

Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten

Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …

News
eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018
Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

News

Spark gains approval for gene therapy, paving way for first $1m treatment

December 20, 2017
Research and Development, Sales and Marketing Spark Therapeutics, biotech, drugs, gene therapy, pharma, pharmaceutical

The FDA handed approval to Spark Therapeutics’ gene therapy for an inherited eye disorder, making it the first treatment of …

News

Pfizer and Spark Therapeutics granted FDA breakthrough designation for haemophilia drug

July 22, 2016
Medical Communications, Research and Development FDA, Pfizer, Spark Therapeutics, haemophilia B, spk-9001

Pfizer and Spark Therapeutics have announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation …

News

Pfizer and Spark Therapeutics present early data on bio-engineered haemophilia drug

May 23, 2016
Research and Development, Sales and Marketing Pfizer, Spark Therapeutics, gene therapy, haemophilia B

Pfizer (NYSE: PFE) and Spark Therapeutics (NASDAQ: ONCE) have announced that they will present data showing encouraging signs in their …

News
spark_logo

Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal

March 11, 2016
Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions

Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024